27 September 2022
Dr Shilpa Nagarajan is one of the MPLS Enterprise and Innovation Fellows for 2022-23.
Intensive blood glucose control for people with type 2 diabetes when they are first diagnosed reduces diabetic complications and prolongs life
21 September 2022
The study, which tracked volunteers for up to 44 years, showed that the benefits of early intensive blood glucose control can persist for decades.
27 October 2021
The University of Oxford is part of a new international research network to investigate the interactions between the biology of the body's internal clock and the disordered physiological processes associated with stroke.
12 October 2021
This interactive and highly successful course returns to the face-to-face format in 3-7 April 2022 for its 18th year.
17 September 2021
12 July 2021
People who get type 2 diabetes need to gain control of their blood-sugar levels — fast. The years immediately after diagnosis are strikingly critical in terms of their future risk for heart attacks and death.
21 May 2020
The DTU is managing the UK sites for a global study testing if either chloroquine or hydroxychloroquine can prevent COVID-19 in vital frontline healthcare workers.